Skip to content

Scholars Compass

· 0 citations · 141 references

TL;DR

New clinically relevant evidence that joint damage and spinal CB 2 receptor expression are correlated combined with converging pre-clinical evidence that activation of CB 2 receptors inhibits central sensitization and its contribution to the manifestation of chronic OA pain is provided.

View source

Similar papers

Review Open access Sep 2026

Neuroplastic mechanisms of chronic pain: Implications and future directions

Chronic pain is now increasingly viewed as aberrant neuroplasticity rather than a protracted expression of peripheral nociception. This review integrates current knowledge through the lens of a peripheral-to-central paradigm, whereby peripheral sensory sensitization contributes to pain initiation, spinal excitation–inh...

Kai-Kai Wang, Yan-Hui He, Jin-Hai Liu et al. · 0 citations
Review Open access Sep 2026

Neuroimmune crosstalk in osteoarthritis pain: from synovial inflammation to pain sensitization

The synovium is examined as an immune niche in OA pain and follows the signals that connect activated macrophages, fibroblast-like synoviocytes, mast cells, T cells, and damaged chondrocytes with nociceptor sensitization.

Zhong-Yan Mao, Kang Wang, Yan-Xuan Wu et al. · 1 citation
Review Open access Oct 2026

Progress in pain mechanisms and management

Pain is a multifaceted sensory and emotional experience that profoundly affects human health and quality of life. It functions as a double-edged sword: while acute pain serves as a protective warning signal, chronic pain compromises physiological and psychological well-being. Pain is now widely regarded as the “fifth v...

Yong-Chang Li, Qian-Qian Chen, Fu-Yong Zhang et al. · 0 citations
Open access Sep 2026

NaV1.7-dependent peripheral sensitization drives chronic pain in Parkinson’s disease

It is demonstrated that dopaminergic neurodegeneration initiated within the brain is sufficient to drive persistent peripheral sensory neuron dysfunction and identify CRMP2-dependent regulation of NaV1.7 as a therapeutic target for Parkinsonian pain.

Tyler S. Nelson, Naomi K. Grabus, Heather N. Allen et al. · 1 citation
Review Open access Sep 2026

The excitatory neurotransmitter glutamate and its receptors: the culprits behind neuropathic pain?

Human understanding of the nature of pain has undergone a profound shift from mechanical reductionism to a multidimensional, integrative approach. Among the many types of chronic pain, neuropathic pain (NP) has long been a key focus of research in the fields of neurobiology and pain medicine, owing to its high prevalen...

Peng-Fei Qi, Zhong-Ren Sun, Hong-Na Yin · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.